Michael Chang

1.4k total citations
28 papers, 657 citations indexed

About

Michael Chang is a scholar working on Pulmonary and Respiratory Medicine, Ophthalmology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Michael Chang has authored 28 papers receiving a total of 657 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pulmonary and Respiratory Medicine, 9 papers in Ophthalmology and 9 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Michael Chang's work include Ocular Oncology and Treatments (9 papers), Retinal Diseases and Treatments (6 papers) and CNS Lymphoma Diagnosis and Treatment (5 papers). Michael Chang is often cited by papers focused on Ocular Oncology and Treatments (9 papers), Retinal Diseases and Treatments (6 papers) and CNS Lymphoma Diagnosis and Treatment (5 papers). Michael Chang collaborates with scholars based in United States, Thailand and Tonga. Michael Chang's co-authors include Katherine L. Molnar-Kimber, James M. Wilson, Michael Lanuti, Daniel H. Sterman, Ashraf A. Elshami, Eun Ha Kang, Larry R. Kaiser, Carol L. Shields, Steven Μ. Albelda and Lauren A. Dalvin and has published in prestigious journals such as Journal of Clinical Oncology, The Journal of Urology and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

Michael Chang

25 papers receiving 642 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michael Chang United States	12	237	147	144	130	120	28	657
Stefan Höcht Germany	13	313 1.3×	12 0.1×	127 0.9×	92 0.7×	119 1.0×	38	521
Peter Royce Australia	15	239 1.0×	77 0.5×	35 0.2×	39 0.3×	7 0.1×	35	791
Elias Mallas Greece	15	130 0.5×	150 1.0×	32 0.2×	199 1.5×	6 0.1×	25	621
Fernando Muñoz Italy	18	604 2.5×	57 0.4×	300 2.1×	230 1.8×	6 0.1×	75	1.0k
Maria Letícia Gobo Silva Brazil	11	175 0.7×	12 0.1×	27 0.2×	136 1.0×	27 0.2×	27	377
J. H. Shepherd United Kingdom	18	125 0.5×	54 0.4×	85 0.6×	217 1.7×	2 0.0×	43	1.2k
C.Norman Coleman United States	11	359 1.5×	10 0.1×	237 1.6×	75 0.6×	6 0.1×	25	733
S. Lasry France	14	119 0.5×	97 0.7×	7 0.0×	243 1.9×	26 0.2×	32	798
I. Strøyer Denmark	10	336 1.4×	14 0.1×	180 1.3×	111 0.9×	6 0.1×	17	695
Adam J. Bograd United States	14	528 2.2×	41 0.3×	9 0.1×	286 2.2×	9 0.1×	45	853

Countries citing papers authored by Michael Chang

Since Specialization

Citations

This map shows the geographic impact of Michael Chang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Chang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Chang more than expected).

Fields of papers citing papers by Michael Chang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Chang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Chang. The network helps show where Michael Chang may publish in the future.

Co-authorship network of co-authors of Michael Chang

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Chang. A scholar is included among the top collaborators of Michael Chang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Chang. Michael Chang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Chang, Michael, et al.. (2022). Epstein-Barr virus-associated lymphoma of the orbit: Case report and review of the literature. American Journal of Ophthalmology Case Reports. 27. 101628–101628. 1 indexed citations

Uribarri, Jaime, Shuchita Sharma, Michael Chang, et al.. (2022). Outcomes of PD for AKI treatment during COVID-19 in New York City: A multicenter study. Peritoneal Dialysis International. 43(1). 13–22. 4 indexed citations

Taylor, J. Michael, Michael Chang, J. Patrick Vaughan, et al.. (2022). Cerebral Arterial Growth in Childhood. Pediatric Neurology. 134. 59–66. 4 indexed citations

Chang, Michael, José A. Canseco, Kristen Nicholson, Neil N. Patel, & Alexander R. Vaccaro. (2020). The Role of Machine Learning in Spine Surgery: The Future Is Now. Frontiers in Surgery. 7. 54–54. 71 indexed citations

Dalvin, Lauren A., Li‐Anne Lim, David Ancona‐Lezama, et al.. (2020). Clinical Features Predictive of Survival in Patients With Vitreoretinal Lymphoma: Analysis of 70 Patients at a Single Ocular Oncology Center. Asia-Pacific Journal of Ophthalmology. 9(2). 110–116. 15 indexed citations

Chang, Michael, Lauren A. Dalvin, Mehdi Mazloumi, et al.. (2020). Prophylactic Intravitreal Bevacizumab After Plaque Radiotherapy for Uveal Melanoma: Analysis of Visual Acuity, Tumor Response, and Radiation Complications in 1131 Eyes Based on Patient Age. Asia-Pacific Journal of Ophthalmology. 9(1). 29–38. 12 indexed citations

Yang, Xiaolu, Lauren A. Dalvin, Mehdi Mazloumi, et al.. (2020). Impact of uveal melanoma thickness on post‐plaque radiotherapy outcomes in the prophylactic anti‐vascular endothelial growth factor era in 1131 patients. Clinical and Experimental Ophthalmology. 48(5). 610–623. 5 indexed citations

Mashayekhi, Arman, Lauren A. Dalvin, Li‐Anne Lim, et al.. (2020). ASSOCIATION OF VITREORETINAL LYMPHOMA WITH SYSTEMIC LYMPHOMA. Retina. 41(2). 259–265. 10 indexed citations

Chang, Michael, Lauren A. Dalvin, Li‐Anne Lim, et al.. (2019). Prophylactic Intravitreal Bevacizumab after Plaque Radiotherapy for Uveal Melanoma: Analysis of 1311 Eyes of 1310 Patients by Age. Investigative Ophthalmology & Visual Science. 60(9). 721–721.

10.

Dalvin, Lauren A., Li‐Anne Lim, Michael Chang, et al.. (2019). Circumscribed choroidal hemangioma: Clinical features and outcomes by age category in 458 cases. Saudi Journal of Ophthalmology. 33(3). 219–228. 9 indexed citations

11.

Chapman, Christina, Megan E.V. Caram, Archana Radhakrishnan, et al.. (2019). Association between PSA values and surveillance quality after prostate cancer surgery. Cancer Medicine. 8(18). 7903–7912. 5 indexed citations

12.

Dalvin, Lauren A., Qiang Zhang, Rose A. Hamershock, et al.. (2019). Nomogram for visual acuity outcome after iodine-125 plaque radiotherapy and prophylactic intravitreal bevacizumab for uveal melanoma in 1131 patients. British Journal of Ophthalmology. 104(5). 697–702. 16 indexed citations

13.

Shields, Carol L., Lauren A. Dalvin, Michael Chang, et al.. (2019). Visual Outcome at 4 Years Following Plaque Radiotherapy and Prophylactic Intravitreal Bevacizumab (Every 4 Months for 2 Years) for Uveal Melanoma. JAMA Ophthalmology. 138(2). 136–136. 44 indexed citations

14.

Morgan, Scott C., Karen E. Hoffman, D.A. Loblaw, et al.. (2018). Hypofractionated Radiation Therapy for Localized Prostate Cancer: An ASTRO, ASCO, and AUA Evidence-Based Guideline. Journal of Clinical Oncology. 36(34). 3411–3430. 129 indexed citations

15.

Cohen, Dan, et al.. (2013). Information Now: Open Access and the Public Good. SMARTech Repository (Georgia Institute of Technology).

16.

Keall, Paul, Michael Chang, Stanley Benedict, et al.. (2008). Investigating the Temporal Effects of Respiratory-Gated and Intensity-Modulated Radiotherapy Treatment Delivery on In Vitro Survival: An Experimental and Theoretical Study. International Journal of Radiation Oncology*Biology*Physics. 71(5). 1547–1552. 24 indexed citations

17.

Keall, Paul, Michael Chang, Stanley Benedict, et al.. (2007). SU‐FF‐T‐270: Investigating the Temporal Effects of Respiratory Gated IMRT Treatment Delivery On in Vitro Survival: A Theoretical and Experimental Study. Medical Physics. 34(6Part11). 2463–2464. 1 indexed citations

18.

Milowsky, Mathew I., Matthew D. Galsky, Daniel J. George, et al.. (2006). Phase I/II trial of the prostate-specific membrane antigen (PSMA)-targeted immunoconjugate MLN2704 in patients (pts) with progressive metastatic castration resistant prostate cancer (CRPC). Journal of Clinical Oncology. 24(18_suppl). 4500–4500. 12 indexed citations

19.

Sterman, Daniel H., Katherine L. Molnar-Kimber, Michael Chang, et al.. (2000). A pilot study of systemic corticosteroid administration in conjunction with intrapleural adenoviral vector administration in patients with malignant pleural mesothelioma. Cancer Gene Therapy. 7(12). 1511–1518. 28 indexed citations

20.

Molnar-Kimber, Katherine L., Daniel H. Sterman, Michael Chang, et al.. (1998). Impact of Preexisting and Induced Humoral and Cellular Immune Responses in an Adenovirus-Based Gene Therapy Phase I Clinical Trial for Localized Mesothelioma. Human Gene Therapy. 9(14). 2121–2133. 167 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact